<p><strong>Rivaroxaban 2.5 mg</strong>:</p>

<ul>
	<li>For the prevention of atherothrombotic events in adult patients after an Acute Coronary Syndrome (ACS) with elevated cardiac biomarkers (Troponin or CK-MB). It is co-administered with Aspirin alone or with Aspirin plus Clopidogrel orTidopidine.</li>
</ul>

<p><strong>Rivaroxaban 10-20 mg</strong>:</p>

<ul>
	<li>To reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation</li>
	<li>Deep vein thrombosis (DVT) &amp; pulmonary embolism (PE) and reduction in the risk of recurrence of DVT and of PE</li>
	<li>For the prophylaxis of DVT, which may lead to PE in patients undergoing knee or hip replacement surgery</li>
</ul>